BRPI0705819A - métodos e kits para análise de efeito de área de cáncer de próstata - Google Patents

métodos e kits para análise de efeito de área de cáncer de próstata

Info

Publication number
BRPI0705819A
BRPI0705819A BRPI0705819-5A BRPI0705819A BRPI0705819A BR PI0705819 A BRPI0705819 A BR PI0705819A BR PI0705819 A BRPI0705819 A BR PI0705819A BR PI0705819 A BRPI0705819 A BR PI0705819A
Authority
BR
Brazil
Prior art keywords
kits
methods
prostate cancer
effect analysis
area effect
Prior art date
Application number
BRPI0705819-5A
Other languages
English (en)
Inventor
Jyoti Mehrotra
Shobha Varde
Karen Gray
Janet Vargo
Abhijit Mazumder
Original Assignee
Johnson & Johnson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson filed Critical Johnson & Johnson
Publication of BRPI0705819A publication Critical patent/BRPI0705819A/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57555—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the prostate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

MéTODOS E KITS PARA ANáLISE DE EFEITO DE áREA DE CáNCER DE PRóSTATA A presente invenção refere-se a métodos e kits para caracterizar câncer de próstata incluem detectar o estado de metilação de diversos genes.
BRPI0705819-5A 2006-10-31 2007-10-31 métodos e kits para análise de efeito de área de cáncer de próstata BRPI0705819A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US85564006P 2006-10-31 2006-10-31

Publications (1)

Publication Number Publication Date
BRPI0705819A true BRPI0705819A (pt) 2008-06-24

Family

ID=38969822

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0705819-5A BRPI0705819A (pt) 2006-10-31 2007-10-31 métodos e kits para análise de efeito de área de cáncer de próstata

Country Status (8)

Country Link
EP (1) EP1918711A3 (pt)
JP (1) JP2008113659A (pt)
KR (1) KR20080039323A (pt)
CN (1) CN101270388A (pt)
BR (1) BRPI0705819A (pt)
CA (1) CA2606589A1 (pt)
IL (1) IL186935A0 (pt)
MX (1) MX2007013726A (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011509688A (ja) * 2008-01-22 2011-03-31 ベリデックス・エルエルシー 前立腺癌におけるｇｓｔｐ１高メチル化の発見
JP2011530287A (ja) * 2008-08-05 2011-12-22 ベリデックス・エルエルシー 前立腺癌メチル化分析
JP2012500197A (ja) 2008-08-15 2012-01-05 ジョージタウン ユニバーシティー Ｒａｓｓｆ１ａ発現およびヒト癌細胞増殖の蛍光調節剤
US11053255B2 (en) 2015-06-22 2021-07-06 Georgetown University Synthesis of mahanine and related compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4458066A (en) 1980-02-29 1984-07-03 University Patents, Inc. Process for preparing polynucleotides
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
GB9609441D0 (en) 1996-05-04 1996-07-10 Zeneca Ltd Process
GB9812768D0 (en) 1998-06-13 1998-08-12 Zeneca Ltd Methods
US6815166B2 (en) * 2001-02-23 2004-11-09 Dana-Farber Cancer Institute, Inc. HIN-1, a tumor suppressor gene
AU2002352745A1 (en) * 2001-11-16 2003-06-10 The Johns Hopkins University School Of Medicine Method of detection of prostate cancer

Also Published As

Publication number Publication date
CA2606589A1 (en) 2008-04-30
EP1918711A2 (en) 2008-05-07
MX2007013726A (es) 2009-02-19
JP2008113659A (ja) 2008-05-22
KR20080039323A (ko) 2008-05-07
EP1918711A3 (en) 2008-07-09
IL186935A0 (en) 2008-02-09
CN101270388A (zh) 2008-09-24

Similar Documents

Publication Publication Date Title
BRPI0801193A2 (pt) detecÇço de cÂncer de pràstata
EP2061899A4 (en) BIOMARKERS FOR PROSTATE CANCER AND METHOD FOR THEIR USE
EP2074422A4 (en) METHOD AND KITS FOR DETECTING PROSTATE CANCER BIOMARKERS
EP2340506A4 (en) BIOMARKER FOR LUNG CANCER AND USE
DK2115472T3 (da) Cancerbiomarkører
CR10667A (es) Compositions and methods for diagnosing and treating cancer
EP2227556A4 (en) LUNG CANCER MARKERS AND THEIR USES
EP2079851A4 (en) SPINK1 AS A PROSTATE TOXIC MARKER AND USE
BRPI0818320A2 (pt) composição para tratamento de câncer de próstata (pca)
BRPI0809137A2 (pt) métodos de diagnosticar, câncer endometrial e pré-câncer classificar e tratar
EP2250287A4 (en) PROOF AND FORECAST OF LUNG CANCER
EP2046375A4 (en) METHOD, COMPOSITIONS AND KITS FOR SELECTIVELY ACTIVATING PROTOXINES BY COMBINATORY TARGETING
EP2332048A4 (en) SANDBOXING WITH CHANGED TOKEN
PL2438445T3 (pl) Sposoby diagnozowania raków gruczołu krokowego
BRPI1011216A2 (pt) simulador de centro de dados
BRPI0921421A2 (pt) sistema de terapia de próstata
EP2340555A4 (en) PROBE BLOCK ARRANGEMENT
PL2733492T3 (pl) Sposób wykrywania nowotworów
EP2068618A4 (en) COMPOSITIONS AND METHODS OF DISCOVERING TUMOR GENES
DK2052011T3 (da) Målrettet polylysin-dendrimer-terapeutisk stof
DK2219683T3 (da) Målrettet radioterapi
EP2281903A4 (en) CANCER MARKER, METHOD FOR EVALUATING CANCER USING THE CANCER MARKER AND ASSESSING THE VALUE
IL220619A (en) Pancreatic cancer markers, detection methods, kits and their biological chips
EP2061498A4 (en) COMPOSITIONS AND METHOD FOR CANCER PREPARATION WITH CUPREDOXINES
MX2007013727A (es) Caracterizacion de cancer de prostata.

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]